Review
Published on 11 Jan 2021
Contamination of Aflatoxins Induces Severe Hepatotoxicity Through Multiple Mechanisms
in Predictive Toxicology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.605823
- 12,427 views
- 71 citations
8 articles related to "Severe Hepatotoxicity"
Articles
Case Report
Published on 12 Nov 2025
Case Report: Accelerated parathyroid adenoma progression and hypercalcemia-driven neurotoxicity following pembrolizumab-based neoadjuvant therapy in triple-negative breast cancer: a case of multisystem immune-related adverse events
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1607957
- 1,259 views
- 1 citation
Case Report
Published on 14 Mar 2024
Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1347896
- 2,138 views
- 5 citations
Case Report
Published on 29 Sep 2025
Pharmacogenomic analysis of alarelin acetate-induced hepatotoxicity: a case report and literature review
in Precision Medicine
Frontiers in Medicine
doi 10.3389/fmed.2025.1634101
- 1,772 views
- 1 citation
Original Research
Published on 30 May 2024
Assessing immune hepatotoxicity of troglitazone with a versatile liver-immune-microphysiological-system
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1335836
- 4,743 views
- 7 citations
Original Research
Published on 26 Jun 2020
Pre-treatment With PLGA/Silibinin Nanoparticles Mitigates Dacarbazine-Induced Hepatotoxicity
in Nanobiotechnology
Frontiers in Bioengineering and Biotechnology
doi 10.3389/fbioe.2020.00495
- 5,821 views
- 17 citations
Original Research
Published on 03 Jan 2022
Ginsenoside Rb1 Attenuates Triptolide-Induced Cytotoxicity in HL-7702 Cells via the Activation of Keap1/Nrf2/ARE Pathway
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.723784
- 5,519 views
- 25 citations
Case Report
Published on 12 Aug 2021
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2021.672233
- 5,925 views
- 19 citations